International Journal of Clinical Pediatric Dentistry

Register      Login

VOLUME 15 , ISSUE 6 ( November-December, 2022 ) > List of Articles


Dental Considerations for the Treatment of Patients with Morquio Syndrome

Anju Vinod, Sunil N Raj, Anitha Anand, Arjun Dilip Shirly

Keywords : Morquio syndrome, Mucopolysaccharidosis, Oral health needs, Treatment implications

Citation Information : Vinod A, Raj SN, Anand A, Shirly AD. Dental Considerations for the Treatment of Patients with Morquio Syndrome. Int J Clin Pediatr Dent 2022; 15 (6):707-710.

DOI: 10.5005/jp-journals-10005-2451

License: CC BY-NC 4.0

Published Online: 14-02-2023

Copyright Statement:  Copyright © 2022; The Author(s).


Aim: Morquio syndrome, also called Mucopolysaccharidosis IV (MPS IV), is a rare autosomal recessive metabolic lysosomal disorder that results in the deposition of glycosaminoglycans (GAGs) in various tissues and organs, resulting in an array of signs and symptoms. The aim of the study was to systematically record the clinical features with a special emphasis on oral manifestations of patients diagnosed with MPS IV and asses the dental treatment implications of the disease manifestations. Materials and methods: A cross-sectional study was conducted on patients diagnosed with MPS IV (n = 26). A complete clinical and oral examination was done and the findings were systemically recorded. Results: The study showed that the patients diagnosed with MPS IV have multiple treatment challenges owing to the range of disease manifestations. Furthermore, they have higher oral health care needs because of the anatomical and pathological changes. Conclusion and clinical significance: Dental professionals must be aware of the implications of the disease manifestation and their accompanying challenges while treating patients with MPS IV. The oral health needs are higher for these patients and regular dental evaluation and treatment must be incorporated into their health care regimen.

PDF Share
  1. Rekka P, Rathna PV, Jagadeesh S, et al. Mucopolysaccharidoses type IV A (Morquio syndrome): a case series of three siblings. J Indian Soc Pedod Prev Dent 2012;30(1):66–69. DOI: 10.4103/0970-4388.95586
  2. Robert M Kliegman, ST Geme, S Behrman. Nelson's Essentials of Pediatrics. 19th edition, Vol 1. Philadelphia: W.B Saunders; 2012: pp 509–516.
  3. Leadley RM, Lang S, Misso K, et al. A systematic review of the prevalence of Morquio A syndrome: challenges for study reporting in rare diseases. Orphanet J Rare Dis 2014;9(1):173. DOI: 10.1186/s13023-014-0173-x
  4. EF Neufeld, J Muenzer. The mucopolysaccharidoses- a lysosomal storage disorder. CR. Scriver, AL. Beaudet, WS. Sly, D. Valle (Eds.), The Metabolic and Molecular Bases of Inherited Disease. 7th edition. New York: McGraw-Hill; 1995: p. 2465.
  5. Sheiham A. Oral health, general health and quality of life. Bull World Health Organ 2005;83(9):644. DOI: 10.1590/S0042-9686 2005000900004
  6. Al-Thihli K, Al-Murshedi F, Al-Hashmi N, et al. Consanguinity, endogamy and inborn errors of metabolism in Oman: a cross-sectional study. Hum Hered 2014;77(1–4):183–188. DOI: 10.1159/000362686
  7. Verma PK, Ranganath P, Dalal AB, et al. Spectrum of lysosomal storage disorders at a medical genetics center in Northern India. Indian Pediatr 2012;49(10):799–804. DOI: 10.1007/s13312-012-0192-4
  8. Bener A, Alali KA. Consanguineous marriage in a newly developed country: the Qatari population. J Biosoc Sci 2006;38(2):239–246. DOI: 10.1017/S0021932004007060
  9. Tomatsu S, Yasuda E, Patel P, et al. Morquio A syndrome: diagnosis and current and future therapies. Pediatr Endocrinol Rev 2014;12 Suppl 1(0 1):141–151.
  10. Montaño AM, Tomatsu S, Gottesman GS, et al. International Morquio A registry: clinical manifestation and natural course of Morquio A disease. J Inherit Metab Dis 2007;30(2):165–174. DOI: 10.1007/s10545-007-0529-7
  11. Hendriksz CJ, Berger KI, Giugliani R, et al. International guidelines for the management and treatment of Morquio A syndrome. Am J Med Genet A 2015;167A(1):11–25. DOI: 10.1002/ajmg.a.36833
  12. White KK, Jester A, Bache CE, et al. Orthopedic management of the extremities in patients with Morquio A syndrome. J Child Orthop 2014;8(4):295–304. DOI: 10.1007/s11832-014-0601-4
  13. Solanki GA, Martin KW, Theroux MC, et al. Spinal involvement in mucopolysaccharidosis IVA (Morquio-Brailsford or Morquio A syndrome): presentation, diagnosis and management. J Inherit Metab Dis 2013;36(2):339–355. DOI: 10.1007/s10545-013-9586-2
  14. Kampmann C, Abu-Tair T, Gökce S, et al. Heart and cardiovascular involvement in patients with mucopolysaccharidosis type IVA (Morquio-A syndrome). PLoS One 2016;11(9):e0162612. DOI: 10.1371/journal.pone.0162612
  15. Hattori T, Wang PL. Calcium antagonists cause dry mouth by inhibiting resting saliva secretion. Life Sci 2007;81(8):683–690. DOI: 10.1016/j.lfs.2007.07.005
  16. Hendriksz CJ, Al-Jawad M, Hawley SM, et al. Clinical overview and treatment options for non-skeletal manifestations of mucopolysaccharidosis type IVA. J Inherit Metab Dis 2013;36(2): 309–322. DOI: 10.1007/s10545-012-9459-0
  17. Murakami J, Shimizu Y. Hepatic manifestations in haematological disorders. Int J Hepatol 2013;2013:484903. DOI: 10.1155/2013/484903
  18. Doherty C, Kubaski F, Tomatsu S, et al. Non-invasive pulmonary function test on Morquio patients. J Rare Dis Res Treat 2017;2(2):55–57. DOI: 10.29245/2572-9411/2017/2.1097
  19. Ponciano S, Sampaio-Maia B, Areias C. Oral manifestations in children with mucopolysaccharidosis. MedicalExpress (São Paulo, online) 2017;4(5):M170504. DOI: 10.5935/MedicalExpress.2017.05.04
  20. Theroux MC, Nerker T, Ditro C, et al. Anaesthetic care and perioperative complications of children with Morquio syndrome. Paediatr Anesth 2012;22(9):901–907. DOI: 10.1111/j.1460-9592.2012.03904.x
  21. Emslie RD, Massler M, Zwemer JD. Mouth breathing: I. Etiology and effects (a review). J Am Dent Assoc 1952;44(5);506–521. DOI: 10.14219/jada.archive.1952.0099
  22. Speidel TM, Isaacson RJ, Worms FW. Tongue-thrust therapy and anterior dental open-bite. A review of new facial growth data. Am J Orthod 1972;62(3):287–295. DOI: 10.1016/s0002-9416(72)90267-9
  23. Ponciano S, Areias C, Leão-Teles E, et al. Hyposalivation, acidic saliva, increased decayed teeth and oral yeast prevalence in children with mucopolysaccharidosis. MedicalExpress (São Paulo, online) 2015;2(5):M150502. DOI: 10.5935/MedicalExpress.2015.05.02
  24. McGovern E, Owens L, Nunn J, et al. Oral features and dental health in Hurler Syndrome following hematopoietic stem cell transplantation. Int J Paediatr Dent 2010;20(5):322–329. DOI: 10.1111/j.1365-263X.2010.01055.x
  25. Torres LC, Soares DC, Kulikowski LD, et al. NK and B cell deficiency in a MPS II family with novel mutation in the IDS gene. Clin Immunol 2014;154(2):100–104. DOI: 10.1016/j.clim.2014.07.001
  26. Schroth RJ, Rabbani R, Loewen G, et al. Vitamin D and dental caries in children. J Dent Res 2016;95(2):173–179. DOI: 10.1177/0022034515616335
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.